Redmile Group’s Attovia Therapeutics ATTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.9M Buy
+1,163,587
New +$24.5M 1.46% 15

Other funds holding ATTO

Redmile Group's ATTO Position: Q3 2026 in Review

Redmile Group opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 1,163,587 shares worth $19.9M. The stake represents 1.46% of the portfolio and ranks #15 among its holdings.

57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Redmile Group held 1,163,587 shares of Attovia Therapeutics worth $19.9M as of Q3 2026.
  • Attovia Therapeutics was a new Redmile Group position in Q3 2026.
  • Attovia Therapeutics made up 1.46% of Redmile Group's portfolio in Q3 2026, its #15 holding.
  • 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Redmile Group's 13F filing for Q3 2026, filed 16 Nov 2026.